h.castellanos

TL2 Moderator · Antalya

Contributes reviews on supplier material. Based in Antalya.

Joined 20 September 2024 · last posted 3d

86 posts, newest first. Showing up to 150.

[2026 update] Regional warehouse stock versus direct despatch Replied, post #146 · Sourcing › Logistics · 25 Jul 2026 · 17 likes On post #142 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #54 · Access › Insurance & coverage · 22 Jul 2026 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. Reimbursement changes: a compound covered one year might not be the next. A formulary…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #128 · Evidence › Journal club · 22 Jul 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Insurance and replacement policies, compared Replied, post #96 · Sourcing › Logistics · 17 Jul 2026 · 1 like Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
What I would want from a home test that does not exist yet — what changed since Replied, post #98 · Analytics › Home & field testing · 17 Jul 2026 · 0 likes This follows post #95 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #41 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 3 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
Second pass at: Absence of evidence and evidence of absence Replied, post #45 · Research Methods › Statistics · 14 Jul 2026 · 1 like This follows post #42 rather than contradicting it. P-values and significance: p
Primary endpoint hierarchies and why order matters — one year on Replied, post #41 · Evidence › Trials · 10 Jul 2026 · 7 likes Picking up post #38: that is the part I would want checked first. Confounding in observational data: a third variable can explain an apparent association. In a…
Hair shedding at month three: mechanism and time course — the long version Replied, post #39 · Practice › Side effects · 3 Jul 2026 · 4 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #12 · Evidence › Journal club · 1 Jul 2026 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
The anatomy of a question that gets answered within an hour Replied, post #94 · Start Here › How to Ask · 29 Jun 2026 · 12 likes On post #90 — agreed on the reasoning, with one qualification. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #86 · Data & Tools › Datasets · 26 Jun 2026 · 10 likes Worth separating two things that post #82 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #28 · Practice › Reconstitution · 16 Jun 2026 · 28 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #2 · Compounds › Retatrutide · 16 Jun 2026 · 22 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Fasting versus non-fasting and which tests care Replied, post #49 · Clinical › Bloodwork · 15 Jun 2026 · 4 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
Pooling trials with different estimands Replied, post #26 · Evidence › Meta-analyses · 15 Jun 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Designing a personal experiment that could change your mind — one year on Replied, post #60 · Research Methods › N-of-1 designs · 14 Jun 2026 · 8 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #19 · Access › Insurance & coverage · 14 Jun 2026 · 2 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Why this subcategory is stricter about sourcing than most Replied, post #40 · Compounds › Secretagogues & GH axis · 8 Jun 2026 · 0 likes This follows post #37 rather than contradicting it. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what…
Alcohol: what is documented and what is folklore Replied, post #41 · Practice › Interactions · 4 Jun 2026 · 2 likes post #40 is right about the mechanism and I think understates the practical bit. Food interactions: most interactions are absorption interactions. Some medications…
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #8 · Compounds › Other compounds · 11 May 2026 · 0 likes post #7 is right about the mechanism and I think understates the practical bit. When "no data" is the complete and final answer: if there is no published human data on…
The "under review" status pill and when a moderator applies it Replied, post #116 · Evidence › Preprints · 5 May 2026 · 13 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #50 · Start Here › Welcome · 2 May 2026 · 3 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
Request: show the solution author in the topic list — what changed since Replied, post #36 · Meta › Feature requests · 2 May 2026 · 7 likes On post #32 — agreed on the reasoning, with one qualification. Requests for platform and documentation features, with the reasoning that justifies them. If you think…
[2026 update] Composite endpoints and the component doing the work Replied, post #72 · Evidence › Trials · 16 Apr 2026 · 5 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
Sample handling between despatch and injection Replied, post #42 · Analytics › Method validation · 15 Apr 2026 · 1 like This follows post #39 rather than contradicting it. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #16 · Evidence › Journal club · 27 Mar 2026 · 29 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
[2026 update] What a purity-only report leaves out Replied, post #62 · Sourcing › Independent verification · 22 Mar 2026 · 0 likes This follows post #59 rather than contradicting it. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks…
Foaming during reconstitution and whether it matters — the long version Replied, post #68 · Practice › Reconstitution · 19 Mar 2026 · 17 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #46 · Sourcing › Logistics · 27 Feb 2026 · 3 likes Worth separating two things that post #42 runs together. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use…
Measurement error in a self-reported exposure Replied, post #2 · Evidence › Study critique · 21 Feb 2026 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
How to ask about something you suspect is a bad idea Replied, post #56 · Start Here › How to Ask · 17 Feb 2026 · 3 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #31 · Analytics › Impurities & related substances · 13 Feb 2026 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #37 · Outcomes › Progress reports · 11 Feb 2026 · 0 likes Worth separating two things that post #33 runs together. Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #5 · Clinical › Special populations · 1 Jan 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
The headache that turns out to be dehydration Replied, post #98 · Nutrition & Training › Hydration & electrolytes · 17 Dec 2025 · 5 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #40 · Sourcing › Regulatory · 12 Dec 2025 · 8 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
Tracking a preprint to publication: a worked example Replied, post #61 · Evidence › Preprints · 6 Dec 2025 · 19 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
Angle of injection and whether 90 degrees is always right Replied, post #58 · Practice › Administration · 30 Nov 2025 · 2 likes Picking up post #55: that is the part I would want checked first. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #29 · Documentation › Doc review · 11 Nov 2025 · 4 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
Documentation that materially improves an appeal's chances Replied, post #56 · Access › Insurance & coverage · 8 Nov 2025 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
EMA product information as a primary source Replied, post #40 · Regional › European Union · 7 Nov 2025 · 22 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
What a purity-only report leaves out Replied, post #75 · Sourcing › Independent verification · 6 Nov 2025 · 20 likes On post #71 — agreed on the reasoning, with one qualification. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation…
Research-use-only labelling: what it means and what it does not Replied, post #53 · Sourcing › Regulatory · 1 Nov 2025 · 20 likes On post #49 — agreed on the reasoning, with one qualification. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials.…
A 40-week log with the measurement method stated Replied, post #85 · Outcomes › Progress reports · 28 Oct 2025 · 26 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Revisiting: German, French and Dutch differences, compared Replied, post #91 · Regional › European Union · 23 Oct 2025 · 22 likes I read post #89 twice before replying, because I had assumed the opposite. Private prescription with self-payment is legal across the EU and is the common route where…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #55 · Analytics › COA interpretation · 12 Oct 2025 · 0 likes I read post #53 twice before replying, because I had assumed the opposite. Purity and content are different measurements: purity tells you what proportion of the…
Follow-up: Subcutaneous absorption kinetics and site differences Started this topic · Pharmacology › Pharmacokinetics · 7 Oct 2025 · 39 likes Subcutaneous absorption kinetics and site differences — setting out what I have, and where I think it stops being reliable. I would like to understand what this number…
What I would record differently if I started again — the long version Replied, post #12 · Outcomes › Progress reports · 5 Oct 2025 · 0 likes Worth separating two things that post #8 runs together. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents…
Managing an unplanned gap in supply — what changed since Replied, post #63 · Access › Shortages · 15 Sep 2025 · 4 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Thyroid function tests during substantial weight change Replied, post #53 · Clinical › Bloodwork · 6 Sep 2025 · 0 likes On post #49 — agreed on the reasoning, with one qualification. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #89 · Evidence › Journal club · 22 Aug 2025 · 7 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
A request that was declined, and the reasoning — a second dataset Replied, post #39 · Documentation › Wiki requests · 9 Aug 2025 · 0 likes This follows post #36 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Canadian access and provincial variation — one year on Replied, post #43 · Regional › North America · 28 Jul 2025 · 23 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #34 · Practice › Dosing & titration · 24 Jul 2025 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2025 · 11 likes This follows post #11 rather than contradicting it. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the…
What this community means by "a source", in practical terms Replied, post #32 · Start Here › Welcome · 12 Jul 2025 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #65 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 5 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
Coming back to: Cross-border purchase rules within the EU Replied, post #8 · Regional › European Union · 9 Jun 2025 · 0 likes Picking up post #5: that is the part I would want checked first. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict…
DXA precision and the least significant change for lean mass — the long version Replied, post #34 · Outcomes › Body composition · 12 May 2025 · 1 like Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
Reading a trial's population section before its results — does this still hold? Replied, post #90 · Evidence › Trials · 11 May 2025 · 3 likes Picking up post #87: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
Follow-up: What other technical communities get right that we do not Replied, post #89 · Lounge › Off topic · 6 May 2025 · 6 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
Second pass at: Reading a combination trial: attributing effect to components Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 28 Apr 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Reaching a dose and staying there for a year: a longitudinal note Replied, post #3 · Practice › Dosing & titration · 27 Apr 2025 · 5 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #27 · Clinical › Comorbidities · 26 Apr 2025 · 2 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
Follow-up: Requesting a page: what makes a good request Replied, post #25 · Documentation › Wiki requests · 23 Apr 2025 · 0 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
Retatrutide dose escalation in the published trials Replied, post #133 · Compounds › Retatrutide · 15 Apr 2025 · 3 likes Picking up post #130: that is the part I would want checked first. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #52 · Compounds › Tirzepatide · 2 Apr 2025 · 31 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Scheduled maintenance and what will be unavailable Replied, post #90 · Meta › Announcements · 29 Mar 2025 · 5 likes Picking up post #87: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #11 · Sourcing › Vendor reports · 15 Mar 2025 · 1 like Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #26 · Pharmacology › Receptor biology · 1 Mar 2025 · 2 likes Coming back to post #24, because the follow-up matters more than the original answer. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure…
Fibre intake when total intake falls, and the constipation link Replied, post #31 · Nutrition & Training › Protein & intake · 21 Feb 2025 · 0 likes post #30 answers the question as asked. The question underneath it is different. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #17 · Clinical › Comorbidities · 19 Feb 2025 · 0 likes Coming back to post #15, because the follow-up matters more than the original answer. Cardiovascular disease: several compounds have cardiovascular outcome trials.…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #95 · Evidence › Meta-analyses · 11 Feb 2025 · 0 likes Worth separating two things that post #91 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
How compounding permissions changed when supply normalised Replied, post #13 · Sourcing › Regulatory · 28 Jan 2025 · 15 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #42 · Compounds › Semaglutide · 28 Jan 2025 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
What changed in 2026, by region Replied, post #48 · Access › International · 30 Dec 2024 · 9 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #134 · Clinical › Prescriber conversations · 29 Dec 2024 · 4 likes I read post #132 twice before replying, because I had assumed the opposite. Preparing for an appointment: bring recent bloodwork, a list of current medications with…
A promotion I argued against, and why I lost Replied, post #24 · Documentation › Doc review · 8 Dec 2024 · 18 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
Converting between mg/mL and units per dose, both directions Replied, post #59 · Practice › Reconstitution · 21 Oct 2024 · 8 likes I read post #57 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #62 · Evidence › Journal club · 3 Oct 2024 · 2 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #2 · Evidence › Journal club · 1 Oct 2024 · 10 likes the opening post answers the question as asked. The question underneath it is different. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
Signs of dehydration worth acting on Replied, post #8 · Safety › Adverse events · 23 Aug 2024 · 1 like post #7 answers the question as asked. The question underneath it is different. Reporting to regulatory agencies: if you have had a serious event, reporting it to the…
Oral contraceptives and delayed emptying: what the data shows Replied, post #36 · Practice › Interactions · 12 Jul 2024 · 4 likes post #35 is right about the mechanism and I think understates the practical bit. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
Cold packs, phase-change material, and what survives ten days Replied, post #58 · Sourcing › Logistics · 30 Jun 2024 · 7 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
The mass-error checker and its intended scope Replied, post #34 · Data & Tools › Calculators · 7 Jun 2024 · 24 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…